tiprankstipranks
Ginkgo Bioworks Holdings, Inc. (DNA)
NYSE:DNA
US Market
DNA
Ginkgo Bioworks Holdings
RESEARCH TOOLSreports
Want to see DNA full AI Analyst Report?

Ginkgo Bioworks Holdings (DNA) Financial Statements

2,303 Followers

Ginkgo Bioworks Holdings Financial Overview

Ginkgo Bioworks Holdings's market cap is currently $489.64M. The company's EPS TTM is $-1.41; its P/E ratio is -1.47; Ginkgo Bioworks Holdings is scheduled to report earnings on February 26, 2026, and the estimated EPS forecast is $-1.21. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 170.16M$ 227.04M$ 251.46M$ 477.71M$ 313.84M
Gross Profit$ 138.63M$ 188.49M$ 197.45M$ 273.49M$ 184.15M
Operating Income$ -315.28M$ -559.76M$ -864.41M$ -2.21B$ -1.83B
EBITDA$ -254.61M$ -484.39M$ -821.29M$ -2.06B$ -1.81B
Net Income$ -312.76M$ -547.03M$ -892.87M$ -2.10B$ -1.83B
Balance Sheet
Cash & Short-Term Investments$ 422.62M$ 561.57M$ 944.07M$ 1.32B$ 1.55B
Total Assets$ 1.12B$ 1.38B$ 1.67B$ 2.54B$ 2.07B
Total Debt$ 417.08M$ 467.73M$ 239.31M$ 442.59M$ 23.03M
Net Debt$ 249.88M$ -93.84M$ -704.76M$ -873.20M$ -1.53B
Total Liabilities$ 611.11M$ 661.39M$ 568.19M$ 803.04M$ 503.61M
Stockholders' Equity$ 508.59M$ 716.06M$ 1.10B$ 1.74B$ 1.51B
Cash Flow
Free Cash Flow$ -178.72M$ -382.13M$ -336.30M$ -304.47M$ -310.34M
Operating Cash Flow$ -171.06M$ -319.58M$ -295.50M$ -252.20M$ -253.82M
Investing Cash Flow$ -240.29M$ -62.24M$ -80.69M$ -67.39M$ -73.26M
Financing Cash Flow$ 17.77M$ -1.74M$ -3.22M$ 95.34M$ 1.53B
Currency in USD

Ginkgo Bioworks Holdings Earnings and Revenue History

Income Statement >

Ginkgo Bioworks Holdings Debt to Assets

Balance Sheet >

Ginkgo Bioworks Holdings Cash Flow

Cash Flow >

Ginkgo Bioworks Holdings Forecast EPS vs Actual EPS

Earnings >